The SimpleScreen CRC blood test, developed by Freenome, will be sold exclusively by Abbott alongside its Cologuard Plus home ...

Medtronic's latest regulatory wins further support its fast-growing arrhythmia-treating cardiac ablation business.

Oura is now citing market uncertainty, shortly after outlining plans to raise as much as $2.2 billion on a $15 billion ...

The European approval covers robotic coronary artery bypasses, as well as procedures to access the heart without opening the breastbone.

Arsenal’s NeoCast system is being developed for subdural hematoma, through the blocking of the brain’s middle meningeal artery.

Sleep-apnea-treatment neuromodulation company Nyxoah says former Teleflex CEO Liam Kelly will take over its corner office, ...

Former Stryker leader Tim Scannell died after a 10-month battle with glioblastoma, his family said in an announcement. He was ...

The financing will support UltraSight's commercial expansion in the United States and the development of new software systems ...

HighLife raised €80 million (more than $90 million U.S.) for a U.S. pivotal study and expanded European commercialization of ...

Precision Neuroscience has raised $250 million in an oversubscribed Series D, which the company said reflects investor ...

Fresenius Medical Care is looking to refocus its operations in China, which represents 6–7% of its Care Enablement operating ...

Activist investor Jana Partners reiterated its calls for the Cooper Companies to sell its vision or surgical divisions and ...